Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy

Stroke

Volumn 29, Issue 1, 1998, Pages 23-28

  Petitti, Diana B ^a   Sidney, Stephen ^b   Quesenberry Jr , Charles P ^b   Bernstein, Allan ^b  

^a SCPMG   (United States)

^b NONE

Author keywords

Cerebral infarction; Cerebrovascular disorders; Hemorrhagic stroke; Ischemic; Stroke

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK;

EID: 0031974089     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.1.23     Document Type: Article

References (13)

1. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennnekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996;335:453-461.
2. Falkeborn M, Persson I, Terent A, Adami HO, Lithell H, Bergstrom R. Hormone replacement therapy and the risk of stroke: follow-up of a population-based cohort in Sweden. Arch Intern Med. 1993;153: 1201-1209.
3. Petitti DB, Wingerd J, Pellegrin F, Ramcharan S. Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA. 1979;242:1150-1154.
4. Rosenberg SH, Fausone V, Clark R. The role of estrogens as a risk factor for stroke in postmenopausal women. West J Med. 1980;133:292-296.
5. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991;151:75-78.
6. Wilson PWF, Garrison J, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study. N Engl J Med. 1985;313:1038-1043.
7. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkmd BM. Cardiovascular mortality and non- contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
8. Pfeffer RI, van Den Nort S. Estrogen use and stroke risk in postmenopausal women. Am J Epidemiol. 1976;103:445-456.
9. Hammond CB, Jelovesk FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy, I: metabolic effects. Am J Obstet Gynecol. 1979;133:525-536.
10. Boysen G, Nyboe J, Appleyard M, Sorensen PS, Boas J, Sommier F, Jensen G, Schnor P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988;19:1145-1153.
11. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users: results from a national cohort. Arch Intern Med. 1993;153:73-79.
12. Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD, Wahl PW, Longstreth WT, Weiss NS, Wagner EH, Prentice R, Furberg CD. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med. 1993;153:1421-1427.
13. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.